Nexalin Technology (NXL) EBIAT (2021 - 2025)
Nexalin Technology has reported EBIAT over the past 5 years, most recently at -$2.4 million for Q4 2025.
- Quarterly results put EBIAT at -$2.4 million for Q4 2025, up 16.12% from a year ago — trailing twelve months through Dec 2025 was -$8.2 million (down 8.08% YoY), and the annual figure for FY2025 was -$8.2 million, down 8.08%.
- EBIAT for Q4 2025 was -$2.4 million at Nexalin Technology, down from -$2.3 million in the prior quarter.
- Over the last five years, EBIAT for NXL hit a ceiling of -$135401.0 in Q3 2022 and a floor of -$2.8 million in Q4 2024.
- Median EBIAT over the past 5 years was -$1.2 million (2024), compared with a mean of -$1.4 million.
- Biggest five-year swings in EBIAT: surged 92.48% in 2022 and later crashed 1596.58% in 2023.
- Nexalin Technology's EBIAT stood at -$595928.0 in 2021, then decreased by 22.44% to -$729677.0 in 2022, then dropped by 6.99% to -$780669.0 in 2023, then plummeted by 262.93% to -$2.8 million in 2024, then grew by 16.12% to -$2.4 million in 2025.
- The last three reported values for EBIAT were -$2.4 million (Q4 2025), -$2.3 million (Q3 2025), and -$1.6 million (Q2 2025) per Business Quant data.